1. Home
  2. NXL vs SIDU Comparison

NXL vs SIDU Comparison

Compare NXL & SIDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • SIDU
  • Stock Information
  • Founded
  • NXL 2010
  • SIDU 2012
  • Country
  • NXL United States
  • SIDU United States
  • Employees
  • NXL N/A
  • SIDU N/A
  • Industry
  • NXL Medical Specialities
  • SIDU Telecommunications Equipment
  • Sector
  • NXL Health Care
  • SIDU Telecommunications
  • Exchange
  • NXL Nasdaq
  • SIDU Nasdaq
  • Market Cap
  • NXL 10.0M
  • SIDU 10.8M
  • IPO Year
  • NXL 2022
  • SIDU 2021
  • Fundamental
  • Price
  • NXL $3.23
  • SIDU $4.55
  • Analyst Decision
  • NXL Hold
  • SIDU Strong Buy
  • Analyst Count
  • NXL 1
  • SIDU 1
  • Target Price
  • NXL N/A
  • SIDU $10.00
  • AVG Volume (30 Days)
  • NXL 533.6K
  • SIDU 19.6M
  • Earning Date
  • NXL 11-08-2024
  • SIDU 11-14-2024
  • Dividend Yield
  • NXL N/A
  • SIDU N/A
  • EPS Growth
  • NXL N/A
  • SIDU N/A
  • EPS
  • NXL N/A
  • SIDU N/A
  • Revenue
  • NXL $162,078.00
  • SIDU $5,189,912.00
  • Revenue This Year
  • NXL $56.86
  • SIDU $36.85
  • Revenue Next Year
  • NXL $167.44
  • SIDU $40.00
  • P/E Ratio
  • NXL N/A
  • SIDU N/A
  • Revenue Growth
  • NXL 26.00
  • SIDU N/A
  • 52 Week Low
  • NXL $0.25
  • SIDU $1.15
  • 52 Week High
  • NXL $4.49
  • SIDU $18.85
  • Technical
  • Relative Strength Index (RSI)
  • NXL 42.43
  • SIDU 71.77
  • Support Level
  • NXL $3.25
  • SIDU $1.16
  • Resistance Level
  • NXL $4.49
  • SIDU $7.65
  • Average True Range (ATR)
  • NXL 0.35
  • SIDU 0.75
  • MACD
  • NXL -0.17
  • SIDU 0.45
  • Stochastic Oscillator
  • NXL 7.26
  • SIDU 51.33

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About SIDU Sidus Space Inc.

Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.

Share on Social Networks: